Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Ulrich Bender

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Opioid Management|April 23, 2021
Switching a baby from IV levomethadone to IV fentanylHans Ulrich Bender, Hans-Georg Muench, Claudia Franziska Nussbaum
Journal of Pain and Symptom Management|June 13, 2017
"Let's Bring Her Home First." Patient Characteristics and Place of Death in Specialized Pediatric Palliative Home CareHans Ulrich Bender, Martin Bernhard Riester, Gian Domenico Borasio, et al.
Journal of Palliative Medicine|October 31, 2013
Specialized pediatric palliative home care: a prospective evaluationGesa Groh, Gian Domenico Borasio, Carla Nickolay, et al.
European Journal of Pediatrics|February 16, 2023
"More life and more days"-patient and care characteristics in a specialized acute pediatric palliative care inpatient unitSophie Stoesslein, Julia D Gramm, Hans-Ulrich Bender, et al.
American Journal of Human Genetics|January 22, 2005
Functional consequences of PRODH missense mutationsHans-Ulrich Bender, Shlomo Almashanu, Gary Steel, et al.
Biomed Research International|July 16, 2014
Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantationMark Reinwald, Eberhard Schleyer, Philipp Kiewe, et al.
Biology of the Cell|March 26, 2013
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implicationsIsabella V Miller, Graca Raposo, Ulrich Welsch, et al.
Oncotarget|August 4, 2016
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrowUwe Thiel, Angela Wawer, Irene von Luettichau, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Opioid Management|April 23, 2021
Switching a baby from IV levomethadone to IV fentanylHans Ulrich Bender, Hans-Georg Muench, Claudia Franziska Nussbaum
Journal of Pain and Symptom Management|June 13, 2017
"Let's Bring Her Home First." Patient Characteristics and Place of Death in Specialized Pediatric Palliative Home CareHans Ulrich Bender, Martin Bernhard Riester, Gian Domenico Borasio, et al.
Journal of Palliative Medicine|October 31, 2013
Specialized pediatric palliative home care: a prospective evaluationGesa Groh, Gian Domenico Borasio, Carla Nickolay, et al.
European Journal of Pediatrics|February 16, 2023
"More life and more days"-patient and care characteristics in a specialized acute pediatric palliative care inpatient unitSophie Stoesslein, Julia D Gramm, Hans-Ulrich Bender, et al.
American Journal of Human Genetics|January 22, 2005
Functional consequences of PRODH missense mutationsHans-Ulrich Bender, Shlomo Almashanu, Gary Steel, et al.
Biomed Research International|July 16, 2014
Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantationMark Reinwald, Eberhard Schleyer, Philipp Kiewe, et al.
Biology of the Cell|March 26, 2013
First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implicationsIsabella V Miller, Graca Raposo, Ulrich Welsch, et al.
Oncotarget|August 4, 2016
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrowUwe Thiel, Angela Wawer, Irene von Luettichau, et al.
Pageof 1